Browsing "Medicine" by Title

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 2657 to 2676 of 11913 < previous   next >
PreviewIssue DateTitleAuthor(s)
2014D-dimer and risk of thromboembolic and bleeding events in patients with atrial fibrillation - observations from the ARISTOTLE trialChristersson, C.; Wallentin, L.; Andersson, U.; Alexander, J.; Ansell, J.; De Caterina, R.; Gersh, B.; Granger, C.; Hanna, M.; Horowitz, J.; Huber, K.; Husted, S.; Hylek, E.; Lopes, R.; Siegbahn, A.
2015Daclatasvir plus peginterferon and ribavirin is noninferior to peginterferon and ribavirin alone, and reduces the duration of treatment for HCV genotype 2 or 3 infectionDore, G.; Lawitz, E.; Hézode, C.; Shafran, S.; Ramji, A.; Tatum, H.; Taliani, G.; Tran, A.; Brunetto, M.; Zaltron, S.; Strasser, S.; Weis, N.; Ghesquiere, W.; Lee, S.; Larrey, D.; Pol, S.; Harley, H.; George, J.; Fung, S.; de Lédinghen, V.; et al.
2017Dacomitinib-induced diarrhoea is associated with altered gastrointestinal permeability and disruption in ileal histology in ratsVan Sebille, Y.; Gibson, R.; Wardill, H.; Secombe, K.; Ball, I.; Keefe, D.; Finnie, J.; Bowen, J.
2012Dacriocistorrinostomia endoscópica = Endoscopic dacryocystorhinostomyRoithmann, R.; Burman, T.; Wormald, P.
2012Dacriocistorrinostomia endoscópica e externa - qual é melhor? = Endoscopic and external dacryocystorhinostomy (DCR) - which is better?Wormald, P.; Roithmann, R.
1997Daily administration of granulocyte colony stimulating factor using a subcutaneous butterflyPegoli, V.; Kotasek, D.
2003Dairy foods and colon cancer preventionMcIntosh, Graeme H.
2013Dairy foods and dairy protein consumption is inversely related to markers of adiposity in obese men and womenMurphy, K.; Crichton, G.; Dyer, K.; Coates, A.; Pettman, T.; Milte, C.; Thorp, A.; Berry, N.; Buckley, J.; Noakes, M.; Howe, P.
2014Dairy-based preexercise meal does not affect gut comfort or time-trial performance in female cyclistsHaakonssen, E.C.; Ross, M.L.; Cato, L.E.; Nana, A.; Knight, E.J.; Jenkins, D.G.; Martin, D.T.; Burke, L.M.
2012Damage Control Resuscitation of the exsanguinating trauma patient: pathophysiology and basic principlesRaith, E.; Frauenfelder, C.; Griggs, W.; Australian Military Medicine Association Conference: Military Health, Shaping the future (AMMA 2011) (21 Oct 2011 - 23 Oct 2011 : Melbourne, Victoria)
2011Damage Control Resuscitation of the exsanguinating trauma patient: pathophysiology and basic principlesFrauenfelder, C.; Raith, E.; Griggs, W.
2017Damage identification on vertebral bodies during compressive loading using digital image correlationGustafson, H.; Melnyk, A.; Siegmund, G.; Cripton, P.
2007Darbepoetin alfa administered monthly maintains haemoglobin concentrations in patients with chronic kidney disease not receiving dialysis: a multicentre, open-label, Australian studyDisney, Alexander Patrick Suffe; De, Jersey, Peter; Kirkland, Geoff; Mantha, Murty; Charlesworth, John A.; Gallagher, Martin; Harris, David C.; Gock, Hilton; Mangos, George J.; MacMillan, J.; Liu, Wei; Viswalingam, Ajit
2015Dark Agouti rat model of chemotherapy-induced mucositis: establishment and current state of the artVanhoecke, B.; Bateman, E.; Mayo, B.; Vanlancker, E.; Stringer, A.; Thorpe, D.; Keefe, D.
2010Dasatinib alters the metastatic phenotype of B16-OVA melanoma in vivoFraser, C.; Lousberg, E.; Guerin, L.; Hughes, T.; Brown, M.; Diener, K.; Hayball, J.
2008Dasatinib cellular uptake and efflux in chronic myeloid leukemia cells: therapeutic implicationsHiwase, D.; Saunders, V.; Hewett, D.; Frede, A.; Zrim, S.; Dang, P.; Eadie, L.; To, L.; Vaz de Melo, J.; Kumar, S.; Hughes, T.; White, D.
2009Dasatinib in the Treatment of Chronic Myeloid Leukemia in Accelerated Phase After Imatinib Failure: The START A TrialApperley, J.; Cortes, J.; Kim, D.; Roy, L.; Roboz, G.; Rosti, G.; Bullorsky, E.; Abruzzese, E.; Hochhaus, A.; Heim, D.; De Souza, C.; Larson, R.; Lipton, J.; Khoury, J.; Kim, H.; Sillaber, C.; Hughes, T.; Erben, P.; Tornout, J.; Stone, R.
2009Dasatinib inhibits recombinant viral antigen-specific murine CD4+ and CD8+ T-cell responses and NK-cell cytolytic activity in vitro and in vivoFraser, C.; Blake, S.; Diener, K.; Lyons, A.; Brown, M.; Hughes, T.; Hayball, J.
2009Dasatinib inhibits the secretion of TNF-α following TLR stimulation in vitro and in vivoFraser, C.; Lousberg, E.; Kumar, R.; Hughes, T.; Diener, K.; Hayball, J.
2009Dasatinib or high-dose Imatinib for chronic-phase chronic myeloid leukemia resistant to Imatinib at a dose of 400 to 600 milligrams daily. Two-year follow-up of a randomized phase 2 study (START-R)Kantarjian, H.; Pasquini, R.; Levy, V.; Jootar, S.; Holowiecki, J.; Hamerschlak, N.; Hughes, T.; Bleickardt, E.; Dejardin, D.; Cortes, J.; Shah, N.